|
Oct 4
|
Is Iovance Biotherapeutics Stock a Buy?
|
|
Oct 3
|
High Growth Tech Stocks to Watch in October 2024
|
|
Sep 26
|
3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow
|
|
Aug 27
|
Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?
|
|
Aug 26
|
High Growth Tech Stocks To Watch In August 2024
|
|
Aug 14
|
This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock
|
|
Aug 13
|
Industry Analysts Just Made A Sizeable Upgrade To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Revenue Forecasts
|
|
Aug 12
|
3 US Growth Companies With High Insider Ownership Growing Earnings Up To 68%
|
|
Aug 10
|
Iovance Biotherapeutics Second Quarter 2024 Earnings: Beats Expectations
|
|
Aug 9
|
Why Iovance Biotherapeutics Shares Are Soaring Today
|
|
Aug 9
|
Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View
|
|
Aug 8
|
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 8
|
Iovance Biotherapeutics: Q2 Earnings Snapshot
|
|
Aug 8
|
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
|
|
Jul 29
|
Why Iovance Biotherapeutics Stock Stumbled Today
|
|
Jul 29
|
Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
|
|
Jul 29
|
Here’s Why Iovance Biotherapeutics (IOVA) Declined in Q2
|
|
Jul 25
|
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
|
|
Jul 2
|
Unveiling Three US Growth Companies With High Insider Ownership
|
|
Jun 28
|
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
|